- $1.44bn
- $1.53bn
- $285.50m
- 58
- 29
- 40
- 38
Annual income statement for MannKind, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 65.1 | 75.4 | 99.8 | 199 | 286 |
| Cost of Revenue | |||||
| Gross Profit | 41 | 38.5 | 44.5 | 141 | 213 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 113 | 140 | 164 | 190 | 228 |
| Operating Profit | -48.2 | -64.2 | -64.1 | 8.68 | 57.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -57.5 | -80.9 | -87.4 | -10.4 | 30.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -57.2 | -80.9 | -87.4 | -11.9 | 27.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -57.2 | -80.9 | -87.4 | -11.9 | 27.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -57.2 | -80.9 | -87.4 | -11.9 | 27.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.249 | -0.246 | -0.331 | -0.034 | 0.158 |